HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Letteria Minutoli Selected Research

Isoflavones

2/2017Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.
2/2012Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats.
8/2007Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Letteria Minutoli Research Topics

Disease

17Wounds and Injuries (Trauma)
02/2018 - 09/2004
12Ischemia
10/2022 - 10/2005
10Reperfusion Injury
01/2016 - 08/2003
9Varicocele
08/2023 - 03/2011
9Inflammation (Inflammations)
04/2022 - 01/2013
9Shock
04/2012 - 06/2002
9Ischemic Stroke
04/2012 - 03/2006
7Neoplasms (Cancer)
04/2024 - 06/2016
7Brain Ischemia (Cerebral Ischemia)
04/2012 - 03/2006
6Necrosis
03/2017 - 03/2006
5Male Infertility (Male Sterility)
08/2023 - 11/2015
5Stroke (Strokes)
11/2011 - 05/2006
4Sepsis (Septicemia)
04/2023 - 02/2012
4Hyperplasia
01/2021 - 02/2003
4Traumatic Brain Injuries (Traumatic Brain Injury)
08/2020 - 03/2012
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2017 - 10/2011
4Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2017 - 03/2009
4Burns
01/2015 - 07/2005
4Myocardial Ischemia (Ischemic Heart Diseases)
04/2012 - 08/2003
4Hypotension (Low Blood Pressure)
07/2008 - 06/2002
3Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 08/2007
3Edema (Dropsy)
01/2018 - 07/2008
3Insulin Resistance
01/2017 - 08/2007
3Brain Injuries (Brain Injury)
06/2015 - 01/2004
3Pancreatitis
05/2011 - 12/2003
3Spermatic Cord Torsion (Testicular Torsion)
04/2009 - 10/2006
3Septic Shock (Toxic Shock Syndrome)
07/2008 - 06/2002
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
11/2007 - 03/2006
2Multiple Myeloma
11/2023 - 11/2021
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 08/2020
2Carcinogenesis
10/2023 - 09/2017
2Hypoxia (Hypoxemia)
08/2023 - 10/2009
2Fibrosis (Cirrhosis)
06/2023 - 01/2023
2Fuchs' Endothelial Dystrophy
04/2022 - 02/2021
2Stomatitis
02/2022 - 06/2021
2Osteoarthritis
01/2022 - 01/2019
2Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 01/2018
2Neuroinflammatory Diseases
08/2021 - 08/2020
2Obesity
07/2021 - 08/2020
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2020 - 10/2016

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2002
19salicylhydroxamic acid (SHAM)IBA
08/2023 - 01/2003
17Messenger RNA (mRNA)IBA
05/2020 - 06/2002
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 09/2004
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 06/2002
12MelanocortinsIBA
04/2012 - 11/2005
11PolydeoxyribonucleotidesIBA
10/2022 - 05/2008
11GenisteinIBA
03/2017 - 08/2007
11NF-kappa B (NF-kB)IBA
02/2009 - 06/2002
7AntioxidantsIBA
10/2023 - 06/2002
7SeleniumIBA
08/2023 - 03/2013
7flavocoxidIBA
04/2023 - 02/2012
7InflammasomesIBA
01/2021 - 12/2015
7Phosphotransferases (Kinase)IBA
01/2018 - 02/2005
7Peptides (Polypeptides)IBA
04/2012 - 11/2005
6LycopeneIBA
08/2023 - 10/2011
6Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2015 - 11/2005
5caryophylleneIBA
11/2023 - 01/2019
5CadmiumIBA
10/2023 - 11/2015
5Testosterone (Sustanon)FDA Link
08/2023 - 10/2011
5Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
04/2022 - 03/2011
5CateninsIBA
01/2022 - 01/2018
5Purinergic P1 Receptors (Adenosine Receptor)IBA
07/2021 - 10/2009
5LipopolysaccharidesIBA
01/2019 - 06/2002
5NF-KappaB Inhibitor alphaIBA
07/2008 - 01/2003
4Malondialdehyde (Propanedial)IBA
05/2020 - 11/2015
4Melanocyte-Stimulating Hormones (MSH)IBA
04/2012 - 02/2011
4Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012 - 04/2006
4Neuroprotective AgentsIBA
03/2012 - 03/2006
4alpha-MSHIBA
08/2009 - 03/2006
4Mitogen-Activated Protein Kinase 3IBA
02/2009 - 10/2004
4Mitogen-Activated Protein KinasesIBA
12/2007 - 02/2005
4JNK Mitogen-Activated Protein KinasesIBA
12/2007 - 10/2004
3Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2013
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2021 - 04/2009
3IsoflavonesIBA
02/2017 - 08/2007
3DystrophinIBA
09/2015 - 03/2006
33,7-dimethyl-1-propargylxanthineIBA
01/2015 - 11/2011
3Interleukin-10 (Interleukin 10)IBA
03/2012 - 02/2011
3Interleukin-6 (Interleukin 6)IBA
03/2012 - 04/2009
3Cholinergic Agents (Cholinergics)IBA
10/2011 - 11/2005
3Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
10/2011 - 03/2006
3CeruletideIBA
05/2011 - 12/2003
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2008 - 07/2005
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2007 - 08/2003
3IRFI 042IBA
03/2006 - 06/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
02/2024 - 11/2021
2Heavy MetalsIBA
10/2023 - 10/2023
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023 - 01/2016
2Glutathione (Reduced Glutathione)IBA
08/2023 - 07/2005
2Fibrillar CollagensIBA
06/2023 - 01/2023
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2023 - 06/2021
2palmidrolIBA
03/2023 - 02/2021
2Adenosine (Adenocard)FDA LinkGeneric
01/2023 - 11/2011
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023 - 11/2015
2CurcuminIBA
01/2022 - 01/2019
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
11/2021 - 01/2019

Therapy/Procedure

3Drug Therapy (Chemotherapy)
08/2023 - 06/2016
3Treatment Delay
08/2009 - 03/2006
2Corneal Transplantation (Keratoplasty)
04/2022 - 02/2021